促销时间表 Estrella Immunopharma, Inc.
先进的时间表
简单图表
关于公司 Estrella Immunopharma, Inc.
Estrella Biopharma, Inc., a preclinical-stage biopharmaceutical company, develops cancer therapeutics. It develops CD19 and CD20-targeted T-cell therapies for the treatment of blood cancers and solid tumors. Estrella Biopharma, Inc. was incorporated in 2022 and is based in Emeryville, California.IPO date | 2021-09-14 |
---|---|
ISIN | US2975841048 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.estrellabio.com |
Цена ао | 1.26 |
每日价格变化: | +8.55% (1.17) |
---|---|
每周价格变化: | +9.48% (1.16) |
每月价格变化: | +22.12% (1.04) |
3个月内价格变化: | +6.72% (1.19) |
六个月内的价格变化: | +16.51% (1.09) |
每年价格变化: | +14.41% (1.11) |
3年内价格变化: | -87.15% (9.88) |
5年内价格变化: | 0% (1.27) |
10年价格变化: | 0% (1.27) |
年初以来价格变化: | +42.7% (0.89) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Owl Creek Asset Management, L.P. | 255000 | 0.72 |
JANE STREET GROUP, LLC | 20505 | 0.06 |
Maso Capital Partners Ltd. | 10000 | 0.03 |
UBS Group AG | 303 | 0 |
Wells Fargo & Company | 73 | 0 |
ETF | 分享, % | 本年盈利能力, % | 股息, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00251 | 17.09 | 1.54048 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Dr. Cheng Liu Ph.D. | CEO, President & Director | N/A | 1967 (58 年) |
Jiandong Xu | Chief Financial Officer | N/A |
地址: United States, EmeryVille. CA, 5858 Horton Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.estrellabio.com
网站: https://www.estrellabio.com